{Reference Type}: Case Reports
{Title}: Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report.
{Author}: Goossens N;Spahr L;Rubbia-Brandt L;
{Journal}: J Hepatol
{Volume}: 59
{Issue}: 5
{Year}: Nov 2013
{Factor}: 30.083
{DOI}: 10.1016/j.jhep.2013.06.003
{Abstract}: Ibandronate is a widely used bisphosphonate with no previously well documented hepatotoxicity. We report the first case of ibandronate-related hepatotoxicity and, to our knowledge, the first case of immune-mediated drug-induced liver injury (DILI) related to bisphosphonates.